PI-88: a novel inhibitor of angiogenesis
Authors:
- 15 October 2008
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 17 (11) , 1769-1776
Abstract
(2008). PI-88: a novel inhibitor of angiogenesis. Expert Opinion on Investigational Drugs: Vol. 17, No. 11, pp. 1769-1776. doi: 10.1517/13543784.17.11.1769Keywords
This publication has 16 references indexed in Scilit:
- Tumor AngiogenesisNew England Journal of Medicine, 2008
- Tumoral Angiogenesis: Review of the LiteratureCancer Investigation, 2008
- A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancerOncogene, 2005
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and AngiogenesisJournal of Clinical Oncology, 2005
- Blockade of Vascular Smooth Muscle Cell Proliferation and Intimal Thickening After Balloon Injury by the Sulfated Oligosaccharide PI-88Circulation Research, 2003
- Heparan sulfate: decoding a dynamic multifunctional cell regulatorTrends in Cell Biology, 2001
- Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factorCancer and Metastasis Reviews, 1996
- The coordinated regulation of heparan sulfate, syndecans and cell behaviorCurrent Opinion in Cell Biology, 1993
- Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptorCell, 1991
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971